Ophthalmological Complications of Aesthetic Medicine Procedures: A Narrative Review
Abstract
1. Introduction
2. Methods
2.1. Search Strategy and Selection Criteria
2.2. Data Extraction and Synthesis
3. Results
3.1. Vascular Complications: Retinal and Ophthalmic Artery Occlusion
3.2. Ocular Motility Disorders: Ptosis, Diplopia, and Strabismus
3.3. Ocular Surface and Adnexal Complications: Dry Eye, Exposure Keratopathy, and Soft Tissue Reactions
3.4. Delayed Inflammatory Reactions: Granulomas and Nodules
3.5. Angioedema and Allergy
3.6. Thread Lift Complications
3.7. Optic Neuropathy and Neurologic Sequelae
3.8. Cerebral Infarction and Neurologic Deficits
3.9. Infectious and Immunologic Sequelae
4. Ocular Complications of Energy-Based Facial Procedures (IPL and Laser)
5. Discussion
6. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Triana, L.; Palacios Huatuco, R.M.; Campilgio, G.; Liscano, E. Trends in surgical and nonsurgical aesthetic procedures: A 14-year analysis of the International Society of Aesthetic Plastic Surgery (ISAPS). Aesthetic Plast. Surg. 2024, 48, 4217–4227. [Google Scholar] [CrossRef] [PubMed]
- Urdiales-Gálvez, F.; Delgado, N.E.; Figueiredo, V.; Lajo-Plaza, J.V.; Mira, M.; Ortíz-Martí, F.; Del Rio-Reyes, R.; Romero-Álvarez, N.; Del Cueto, S.R.; Segurado, M.A.; et al. Preventing the complications associated with the use of dermal fillers in facial aesthetic procedures: An expert group consensus report. Aesthetic Plast. Surg. 2017, 41, 667–677. [Google Scholar] [CrossRef] [PubMed]
- Zhao, F.; Chen, Y.; He, D.; You, X.; Xu, Y. Disastrous cerebral and ocular vascular complications after cosmetic facial filler injections: A retrospective case series study. Sci. Rep. 2024, 14, 3495. [Google Scholar] [CrossRef] [PubMed]
- Walker, L.; Convery, C.; Davies, E.; Murray, G.; Croasdell, B. Consensus Opinion for The Management of Soft Tissue Filler Induced Vision Loss. J. Clin. Aesthet. Dermatol. 2021, 14, E84–E94. [Google Scholar]
- Beleznay, K.; Carruthers, J.D.; Humphrey, S.; Jones, D. Avoiding and treating blindness from fillers: A review of the world literature. Dermatol. Surg. 2015, 41, 1097–1117. [Google Scholar] [CrossRef]
- Cavallini, M.; Cirillo, P.; Fundarò, S.P.; Quartucci, S.; Sciuto, C.; Sito, G.; Tonini, D.; Trocchi, G.; Signorini, M. Safety of botulinum toxin A in aesthetic treatments: A systematic review of clinical studies. Dermatol. Surg. 2014, 40, 525–536. [Google Scholar] [CrossRef] [PubMed]
- Foster, J.; Aakalu, V.K.; Freitag, S.K.; McCulley, T.J.; Tao, J.P.; Vagefi, M.R.; Yen, M.T.; Kim, S.J.; Wladis, E.J. Vision-Threatening Complications of Soft Tissue Fillers: A Report by the American Academy of Ophthalmology. Ophthalmology 2025, 132, 935–944. [Google Scholar] [CrossRef] [PubMed]
- Doyon, V.C.; Liu, C.; Fitzgerald, R.; Humphrey, S.; Jones, D.; A Carruthers, J.D.; Beleznay, K. Update on Blindness From Filler: Review of Prognostic Factors, Management Approaches, and a Century of Published Cases. Aesthetic Surg. J. 2024, 44, 1091–1104. [Google Scholar] [CrossRef]
- Beleznay, K.; Carruthers, J.D.; Humphrey, S.; Jones, D. Update on Avoiding and Treating Blindness from Fillers: A Recent Review of the World Literature. Aesthetic Surg. J. 2019, 39, 662–674. [Google Scholar] [CrossRef]
- Kapoor, K.M.; Kapoor, P.; Heydenrych, I.; Bertossi, D. Vision Loss Associated with Hyaluronic Acid Fillers: A Systematic Review of the Literature. Aesthetic Plast. Surg. 2020, 44, 929–944. [Google Scholar] [CrossRef]
- Carruthers, J.D.; Fagien, S.; Rohrich, R.J.; Weinkle, S.; Carruthers, A. Blindness caused by cosmetic filler injection: A review of cause and therapy. Plast. Reconstr. Surg. 2014, 134, 1197–1201. [Google Scholar] [CrossRef]
- Steinsapir, K.D.; Groth, M.J.; Boxrud, C.A. Persistence of upper blepharoptosis after cosmetic botulinum toxin type A. Dermatol. Surg. 2015, 41, 833–840. [Google Scholar] [CrossRef]
- Park, S.W.; Woo, S.J.; Park, K.H.; Huh, J.W.; Jung, C.; Kwon, O. Iatrogenic retinal artery occlusion caused by cosmetic facial filler injections. Am. J. Ophthalmol. 2012, 154, 653–662.e1. [Google Scholar] [CrossRef]
- Kim, Y.K.; Jung, C.; Woo, S.J.; Park, K.H. Cerebral Angiographic Findings of Cosmetic Facial Filler-Related Ophthalmic and Retinal Artery Occlusion. J. Korean Med. Sci. 2015, 30, 1846–1855. [Google Scholar] [CrossRef] [PubMed]
- Ansari, Z.A.; Choi, C.J.; Rong, A.J.; Erickson, B.P.; Tse, D.T. Ocular and cerebral infarction from periocular filler injection. Orbit 2019, 38, 322–324. [Google Scholar] [CrossRef] [PubMed]
- Lee, Y.J.; Woo, S.J. Long-term outcomes of ophthalmic and retinal artery occlusion after cosmetic facial filler injection. Aesthetic Surg. J. 2022, 42, 196–204. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Massry, G.G.; Holds, J.B. Complications of Periocular Dermal Fillers. Facial Plast. Surg. Clin. N. Am. 2021, 29, 349–357. [Google Scholar] [CrossRef]
- Funt, D.; Pavicic, T. Dermal Fillers in Aesthetics: An Overview of Adverse Events and Treatment Approaches. Clin. Cosmet. Investig. Dermatol. 2013, 6, 295–316. [Google Scholar] [CrossRef]
- Botha, V.E.; Insull, E.A. Causes and management of sight-threatening complications of dermal filler injections: A review. Clin. Exp. Ophthalmol. 2024, 52, 365–373. [Google Scholar] [CrossRef]
- Mortada, H.; Seraj, H.; Barasain, O.; Bamakhrama, B.; Alhindi, N.I.; Arab, K. Ocular complications post-cosmetic periocular hyaluronic acid injections: A systematic review. Aesthetic Plast. Surg. 2022, 46, 760–773. [Google Scholar] [CrossRef] [PubMed]
- Kothari, M.; Shukri, N.; Quayyum, A. Transient superior oblique paresis after injection of botulinum toxin A for facial rejuvenation. Indian J. Ophthalmol. 2012, 60, 77–78. [Google Scholar] [CrossRef] [PubMed]
- Khan, S.; Pathak, G.; Milgraum, D.; Tamhankar, M.; Milgraum, S. Double vision due to lateral rectus injury after cosmetic botulinum toxin injections. Australas. J. Dermatol. 2023, 64, e220–e223. [Google Scholar] [CrossRef] [PubMed]
- Delle Chiaie, T. Diplopia Secondary to Neurotoxin Injections: Prevention, Diagnosis, and Management. J. Clin. Aesthet. Dermatol. 2024, 17 (Suppl. S1), S30–S36. [Google Scholar] [PubMed]
- Aristodemou, P.; Watt, L.; Baldwin, C.; Hugkulstone, C. Diplopia associated with the cosmetic use of botulinum toxin A for facial rejuvenation. Ophthalmic Plast. Reconstr. Surg. 2006, 22, 134–136. [Google Scholar] [CrossRef] [PubMed]
- Karam, E.Z.; Gan, A.; Muci-Mendoza, R.; Martinez, E.; Perez, E. Visual Loss After Platelet-Rich Plasma Injection into the Face. Neuroophthalmology 2020, 44, 371–378. [Google Scholar] [CrossRef] [PubMed]
- Nomoto, S.; Ogawa, R. Management of secondary embolization that arose after intraarterial thrombolytic treatment of cosmetic facial filler-induced arterial occlusion. JPRAS Open 2021, 28, 25–28. [Google Scholar] [CrossRef]
- Friedman, R.; Coombs, A.V.; Stevens, S.; Lisman, R.D.; Chiu, E.S. Complete Vision Recovery After Filler-Induced Blindness Using Hyperbaric Oxygen Therapy: Case Report and Literature Review. Aesthetic Surg. J. Open Forum 2024, 6, ojae036. [Google Scholar] [CrossRef]
- Paap, M.K.; Milman, T.; Ugradar, S.; Goldberg, R.; Silkiss, R.Z. Examining the Role of Retrobulbar Hyaluronidase in Reversing Filler-Induced Blindness: A Systematic Review. Ophthalmic Plast. Reconstr. Surg. 2020, 36, 554–561. [Google Scholar] [CrossRef]
- Başar, E.; Arıcı, C. Use of Botulinum Neurotoxin in Ophthalmology. Turk. J. Ophthalmol. 2016, 46, 282–290. [Google Scholar] [CrossRef]
- Isaac, C.R.; Chalita, M.R.; Pinto, L.D. Botox® after Botox®-a new approach to treat diplopia secondary to cosmetic botulinic toxin use: Case reports. Arq. Bras. Oftalmol. 2012, 75, 213–214. [Google Scholar] [CrossRef]
- Bacharach, J.; Lee, W.W.; Harrison, A.R.; Freddo, T.F. A review of acquired blepharoptosis: Prevalence, diagnosis, and current treatment options. Eye 2021, 35, 2468–2481. [Google Scholar] [CrossRef] [PubMed]
- Kroumpouzos, G.; Kassir, M.; Gupta, M.; Patil, A.; Goldust, M. Complications of Botulinum toxin A: An update review. J. Cosmet. Dermatol. 2021, 20, 1585–1590. [Google Scholar] [CrossRef] [PubMed]
- Hong, G.W.; Hu, H.; Chang, K.; Park, Y.; Lee, K.W.A.; Chan, L.K.W.; Yi, K.H. Review of the Adverse Effects Associated with Dermal Filler Treatments: Part I Nodules, Granuloma, and Migration. Diagnostics 2024, 14, 1640. [Google Scholar] [CrossRef] [PubMed]
- Arlette, J.P.; Froese, A.L.; Singh, J.K. Soft Tissue Filler Therapy and Informed Consent: A Canadian Review. J. Cutan. Med. Surg. 2022, 26, 50–56. [Google Scholar] [CrossRef]
- Zein, M.; Tie-Shue, R.; Pirakitikulr, N.; Lee, W.W. Complications after cosmetic periocular filler: Prevention and management. Plast. Aesthetic Res. 2020, 7, 44. [Google Scholar] [CrossRef] [PubMed]
- Wilde, C.L.; Gupta, A.; Lee, S.; Ezra, D.G. Tear Trough Filler Using the Three-point Tangent Technique: Lessons from 1452 Tear Trough Applications. Plast. Reconstr. Surg. Glob. Open 2023, 11, e5060. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.L.; Li, Z.H.; Chen, X.Y.; Xing, W.S.; Hu, J.T. Facial Thread Lifting Complications in China: Analysis and Treatment. Plast. Reconstr. Surg. Glob. Open 2021, 9, e3820. [Google Scholar] [CrossRef] [PubMed]
- Alawami, A.Z.; Tannous, Z. Late-onset hypersensitivity reaction to hyaluronic acid dermal fillers manifesting as cutaneous and visceral angioedema. J. Cosmet. Dermatol. 2021, 20, 1483–1485. [Google Scholar] [CrossRef] [PubMed]
- Nguyen, D.T.; Cohen, J.L.; Nogueira, A.; Lane, V.; Andriopolos, B. Postmarket safety surveillance of delayed complications for recent FDA-approved hyaluronic acid dermal fillers. Dermatol. Surg. 2022, 48, 220–224. [Google Scholar]
- Zeineddine, R.; Abou Khater, D.; Mouawad, Y.; Hamieh, C.; El-Hussein, M. Herpes zoster ophthalmicus (HZO) secondary to platelet-rich plasma (PRP) therapy-A case report. Heliyon 2023, 9, e22815. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Gentile, P.; Garcovich, S. Systematic review of platelet-rich plasma use in androgenetic alopecia compared with Minoxidil®, Finasteride®, and adult stem cell-based therapy. Int. J. Mol. Sci. 2020, 21, 2702. [Google Scholar] [CrossRef]
- Lee, W.W.; Murdock, J.; Albini, T.A.; O’brien, T.P.; Levine, M.L. Ocular damage secondary to intense pulse light therapy to the face. Ophthalmic Plast. Reconstr. Surg. 2011, 27, 263–265. [Google Scholar] [CrossRef] [PubMed]
- Jewsbury, H.; Morgan, F. Uveitis and iris photoablation secondary to intense pulsed light therapy. Can. J. Ophthalmol. 2012, 47, e13–e14. [Google Scholar] [CrossRef] [PubMed]
- Crabb, M.; Chan, W.O.; Taranath, D.; Huilgol, S.C. Intense pulsed light therapy (IPL) induced iritis following treatment for a medial canthal capillary malformation. Australas. J. Dermatol. 2014, 55, 289–291. [Google Scholar] [CrossRef] [PubMed]
- Gulmez Sevim, D.; Oner, A.O.; Unlu, M.; Mirza, G.E. Ocular complications after cosmetic periocular diode laser application to the eyelids. J. Cosmet. Laser Ther. 2018, 20, 447–448. [Google Scholar] [CrossRef] [PubMed]
- Karabela, Y.; Eliaçık, M. Anterior uveitis following eyebrow epilation with alexandrite laser. Int. Med. Case Rep. J. 2015, 8, 177–179. [Google Scholar] [CrossRef]
- Yalçındağ, F.N.; Uzun, A. Anterior uveitis associated with laser epilation of eyebrows. J. Ophthalmic Inflamm. Infect. 2013, 3, 45. [Google Scholar] [CrossRef]
- Brilakis, H.S.; Holland, E.J. Diode-laser-induced cataract and iris atrophy as a complication of eyelid hair removal. Am. J. Ophthalmol. 2004, 137, 762–763. [Google Scholar]
- Lin, C.C.; Tseng, P.C.; Chen, C.C.; Woung, L.C.; Liou, S.W. Iritis and pupillary distortion after periorbital cosmetic alexandrite laser. Graefes Arch. Clin. Exp. Ophthalmol. 2011, 249, 783–785. [Google Scholar] [CrossRef] [PubMed]
- Schelke, L.; Velthuis, P.J.; Lowry, N.; Rohrich, R.J.; Swift, A.; Alfertshofer, M.; Frank, K.; Gotkin, R.H.; Cotofana, S. Precision in midfacial volumization using ultrasound-assisted cannula injections. Plast. Reconstr. Surg. 2023, 152, 67–74. [Google Scholar] [CrossRef]
Key Messages |
---|
Ophthalmologic complications from aesthetic procedures, though rare, can be severe and irreversible. Prevention is paramount, as effective treatments are often limited. |
Retinal artery occlusion (RAO) due to filler embolism is the most devastating complication. Even with prompt treatment, vision prognosis is usually poor. Early recognition and urgent intervention (within minutes) are essential to attempt to mitigate visual damage. |
Injections in high-risk facial zones (e.g., glabella, nasal dorsum) have the greatest risk of vision-threatening complications. Use extreme caution if treating these areas (or consider avoiding them for fillers). |
Employ safe injection techniques: whenever possible, use microcannulas instead of sharp needles in high-risk areas, inject slowly with minimal pressure (e.g., thumb on plunger), and aspirate before injecting (recognizing that aspiration is not 100% reliable). Small aliquots (<0.1 mL per injection) can reduce the chance of large emboli. |
Proper injector training and anatomical knowledge are critical. Many severe complications occurred with injectors lacking specific oculofacial anatomy training. Practitioners should be credentialed and thoroughly trained, especially when operating near the eyes. |
Informed consent is essential. Patients should be made aware of even the rare risks (blindness, stroke, etc.) before undergoing procedures. |
Be prepared: have a “filler complication kit” ready (e.g., hyaluronidase, aspirin) and an emergency referral pathway to an ophthalmologist on call. At the first sign of visual symptoms, stop injection immediately and initiate emergency management. |
Even non-injectable treatments can cause ocular injury. Ensure eye protection (e.g., metal corneal shields) during intense pulsed light (IPL) or laser procedures near the eyes. Improper use of these devices can lead to serious complications like corneal burns, uveitis, iris atrophy, or cataract. |
Botulinum toxin complications (ptosis, diplopia) are usually transient and self-limited. Use precise technique (e.g., avoid injecting too close to the orbital rim, correct dosing) to minimize these side effects. |
No guaranteed “antidote” exists for many of these complications. Once a filler embolus causes ischemia or a toxin diffuses improperly, reversing the damage is difficult. Thus, prevention remains the main strategy and is far better than any cure. |
Complication | Estimated Frequency | Management | Relevant Notes |
---|---|---|---|
Central Retinal Artery Occlusion (CRAO) [3,4,5,7,9,13,14,15,16,27,28]. | 1 in 100,000 injections | Urgent: retrobulbar hyaluronidase (if HA), hyperbaric oxygen, ocular massage, antiplatelets. Prognosis is poor. | High visual morbidity. Prompt diagnosis and treatment are critical. |
Ischemic Optic Neuropathy (AION/NAION) [7,9,25]. | Extremely rare (only isolated cases reported) | Systemic steroids, visual support. Usually irreversible. | May coexist with CRAO. Requires clinical and angiographic assessment. |
Diplopia / Extraocular muscle palsy [21,22,23,24,29,30]. | 0.7–2.2% | Observation, prisms, eye patch. Usually resolves spontaneously. | May be due to botulinum toxin or ischemia from fillers. |
Palpebral Ptosis [6,12,31]. | 2.5% | Topical apraclonidine, observation. Resolution in 2–8 weeks. | Related to toxin diffusion to levator muscle. |
Dry Eye/Lagophthalmos [6,31,32]. | ≈3% | Artificial tears, ointments, night time lid closure. Improves with muscle recovery. | Mainly due to orbicularis oculi paralysis after toxin. |
Periocular Skin Necrosis [3,4,5,7,9,25,26]. | ≈1–3% | Urgent: Hyaluronidase (if HA), antibiotics, hyperbaric oxygen. Prevent exposure-related damage. | Urgent reperfusion is needed to avoid scarring and visual sequelae. |
Granulomas/Inflammatory Nodules [33,34]. | <1% | Hyaluronidase, intralesional corticosteroids, antibiotics or surgical excision if needed. | Frequent with permanent fillers or biofilm reactions. |
Cellulitis / Periocular Infection [33,34,35]. | ≈6% | Oral or IV antibiotics depending on severity. Drain abscesses if present. | Differential diagnosis of delayed swelling. Requires close monitoring. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
De-Pablo-Gómez-de-Liaño, L.; Ly-Yang, F.; Burgos-Blasco, B.; Fernández-Vigo, J.I. Ophthalmological Complications of Aesthetic Medicine Procedures: A Narrative Review. J. Clin. Med. 2025, 14, 5399. https://doi.org/10.3390/jcm14155399
De-Pablo-Gómez-de-Liaño L, Ly-Yang F, Burgos-Blasco B, Fernández-Vigo JI. Ophthalmological Complications of Aesthetic Medicine Procedures: A Narrative Review. Journal of Clinical Medicine. 2025; 14(15):5399. https://doi.org/10.3390/jcm14155399
Chicago/Turabian StyleDe-Pablo-Gómez-de-Liaño, Lucía, Fernando Ly-Yang, Bárbara Burgos-Blasco, and José Ignacio Fernández-Vigo. 2025. "Ophthalmological Complications of Aesthetic Medicine Procedures: A Narrative Review" Journal of Clinical Medicine 14, no. 15: 5399. https://doi.org/10.3390/jcm14155399
APA StyleDe-Pablo-Gómez-de-Liaño, L., Ly-Yang, F., Burgos-Blasco, B., & Fernández-Vigo, J. I. (2025). Ophthalmological Complications of Aesthetic Medicine Procedures: A Narrative Review. Journal of Clinical Medicine, 14(15), 5399. https://doi.org/10.3390/jcm14155399